Latest Safety News

Alcidion has secured its first contract in Wales with Hywel Dda University Health Board, deploying its Miya Precision Platform to enhance patient flow and clinical communication over five years.

Vulcan Steel Limited reported a 12.6% revenue decline and a 64.8% drop in net profit for the first half of FY25 amid challenging market conditions. Despite this, the company achieved a 10% return on capital employed and is positioning itself for growth as economic recovery signs emerge.

Vulcan Steel Limited reported a challenging first half of FY25 with significant declines in revenue, EBITDA, and net profit, yet maintained a solid 10% return on capital employed and declared a cautious interim dividend.

Zenith Minerals has secured Program of Work approval to launch a new drilling campaign at its Dulcie Far North gold project, following a 40% resource increase. The company is also advancing development studies and exploring multiple new regional gold targets.

Alterity Therapeutics has raised A$40 million through a two-tranche placement to advance its lead compound ATH434 for neurodegenerative diseases, including Multiple System Atrophy and Parkinson's disease.

Eskan Company has received conditional approval for C$13.5 million in funding from Canada’s Critical Minerals Infrastructure Fund to advance the Trans-Atikh Project, a key infrastructure initiative supporting lithium development in Quebec’s Eeyou Istchee James Bay region.

CLINUVEL has released preliminary data from its CUV052 study showing SCENESSE® is well tolerated in adolescent erythropoietic protoporphyria (EPP) patients, supporting a planned label extension in 2025.

PYC Therapeutics has secured regulatory approval to initiate human trials of PYC-003, a novel drug candidate targeting the root cause of Polycystic Kidney Disease (PKD). Initial safety and efficacy data are expected within 2025, marking a critical step in addressing a disease affecting millions worldwide.

JB Hi-Fi Limited reported a robust 9.8% increase in HY25 sales to AUD 5.67 billion and an 8.0% rise in net profit, supported by its recent acquisition of e&s Trading Co. Despite strong momentum, the company remains cautious about competitive pressures ahead.

KGL Resources Limited has released a comprehensive feasibility study update for its Jervois Copper Project, confirming its technical robustness and financial viability with plans to commence production in 2027. The project boasts a post-tax net present value of A$405 million and aims to produce around 30,000 tonnes of copper annually, positioning itself to capitalize on a tightening global copper market.

Ansell Limited reports robust FY25 half-year results, driven by strong organic sales and EBIT growth, while accelerating its KBU integration and productivity initiatives.

Nyrada has secured ethics approval to begin its first-in-human Phase Ia trial of NYR-BI03, a promising neuro- and cardioprotective drug candidate. Recruitment starts soon, with dosing expected by March and results due in Q3 2025.